Real-world Treatment Patterns and MRI Utilization Among Lecanemab Patients in a Commercial and Medicare Insured Population

Long-term Benefit of Lecanemab in Patients with Low Baseline Amyloid: Estimation of Time Saved

Health Disparities and Diagnostic Challenges in Anti-Amyloid Therapy Implementation: A Rural Texas Experience